Frontline combination of ponatinib and hyper‐CVAD in Philadelphia chromosome‐positive acute lymphoblastic leukemia: 80‐months follow‐up results
暂无分享,去创建一个
G. Garcia-Manero | Xuelin Huang | F. Ravandi | E. Jabbour | C. Dinardo | S. O'brien | N. Pemmaraju | N. Jain | N. Short | J. Jorgensen | S. Loghavi | P. Kebriaei | I. Khouri | K. Sasaki | H. Kantarjian | R. Garris | W. Wierda | M. Kwari | F. Haddad | Rebecca E. Garris